Michael J. Farrell - 16 Nov 2023 Form 4/A - Amendment Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Issuer symbol
RMD
Transactions as of
16 Nov 2023
Transactions value $
$7,908,732
Form type
4/A - Amendment
Filing time
20 Nov 2023, 21:14:46 UTC
Date Of Original Report
20 Nov 2023
Previous filing
16 Nov 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $200K +3.46K +0.79% $57.76 444K 16 Nov 2023 Direct F1
transaction RMD ResMed Common Stock Tax liability -$200K -1.34K -0.3% $148.90 443K 16 Nov 2023 Direct F2
transaction RMD ResMed Common Stock Tax liability -$350K -2.35K -0.53% $148.94 441K 20 Nov 2023 Direct F3
holding RMD ResMed Common Stock 4.09K 16 Nov 2023 Lisette and Michael Farrell Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -3.46K -100% $0.00* 0 16 Nov 2023 ResMed Common Stock 3.46K $57.76 Direct F4
transaction RMD ResMed Common Stock Options Award $8.26M +55.5K $148.90 55.5K 16 Nov 2023 ResMed Common Stock 55.5K $148.90 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Original form amended to include a plan provision auto-exercise prior to option grant expiration.
F2 Disposition to issuer for exercise cost of options auto-exercised under the plan.
F3 Disposition to issuer for tax withholding on vesting of Performance Restricted Stock Units granted on 11/19/2020.
F4 Transaction was a plan auto exercise prior to expiration.
F5 Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2024, 2025, and 2026.